Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on developing melanocortin-4 receptor (MC4R) agonists to treat rare neuroendocrine diseases characterized by hyperphagia and severe obesity. Its lead product, IMCIVREE, is marketed in multiple countries for conditions like Bardet-Biedl syndrome, Prader-Willi syndrome, and hypothalamic obesity.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.